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Abstract
Glycobiology is a glycan-based field of study that focuses on the structure,
function, and biology of carbohydrates, and glycomics is a sub-study of the field of
glycobiology that aims to define structure/function of glycans in living organisms.
With the popularity of the glycobiology and glycomics, application of computa-
tional modeling expanded in the scientific area of glycobiology over the last
decades. The recent availability of progressive Wet-Lab methods in the field of
glycobiology and glycomics is promising for the impact of systems biology on the
research area of the glycome, an emerging field that is termed “systems
glycobiology.” This chapter will summarize the up-to-date leading edge in the use
of bioinformatics tools in the field of glycobiology. The chapter provides basic
knowledge both for glycobiologists interested in the application of bioinformatics
tools and scientists of computational biology interested in studying the glycome.
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1. Introduction
Glycans are long chains of carbohydrate-based polymers composed of repeating
units of monosaccharide monomers bound together by glycosidic linkages. Com-
plex and diverse glycans appear to be ever-present macromolecules in all cells in
nature, and essential to all biological systems. Glycans play physical, structural, and
metabolic roles in living organisms [1]. In the last century, knowledge on the
biochemistry and biology of nucleic acids and proteins rapidly increased. Never-
theless, it has been much more difficult to understand the biology of glycans, which
are main component of the cell surface [2]. The biosynthesis mechanism of glycans
is totally different from those of nucleic acids and proteins. Biological mechanism of
glycans is complex, which makes analysis of them extremely difficult and limits our
understanding of mechanisms responsible for biological functions of glycans [3].
After the genomics revolution and development of high-throughput technologies,
scientific interests increased to understand the characterization, function, and
interaction of other significant biomolecules (e.g., DNA transcripts, proteins, lipids,
and glycans) for the cell. These interests resulted in emergence of other omic types
such as transcriptomics, proteomics, metabolomics, lipidomics and glycomics [4].
From the perspective of evolutionary conservation, conservation decreased in the
order genomics, transcriptomics, proteomics, metabolomics, lipidomics, and
glycomics. On the other hand, reverse order is present for informational diversity of
these fields of omics (Figure 1) [5].
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With the progress in high-throughput technologies, studies on glycobiology
increased to screen cells quickly and generate huge glycomics data sets. Moreover,
advanced analytical techniques and tools for data analysis provide possibility to
improve high-throughput techniques for screening glycans as a marker of diseases
and to classify structure of glycans in therapeutic proteins [6].
2. Glycans
Glycans are linear or branched sugar macromolecules composed of repeating
monosaccharides linked glycosidically. Beside nucleic acids and protein, glycans are
known as the third dimension in molecular biology [7, 8]. These macromolecules
can be found in the form of heteropolysaccharides or homopolysaccharides. Fur-
thermore, glycoconjugates (glycolipid, glycoprotein and proteoglycan), can be also
considered as glycan despite the fact that the carbohydrate part of glycoconjugates
are only oligosaccharides [9]. In glycoproteins, oligosaccharides and proteins can be
linked in different forms, namely N-linked glycans and O-linked glycans. N-
acetylglucosamine is linked to the amide side chain of asparagine in N-linked
glycans. C-1 of N-acetylgalactosamine is linked to the hydroxyl function of serine or
threonine in O-linked glycans [10].
With the increasing researches in glycoscience, many different roles of glycans
in biological systems have been revealed in the last decades. Significant functions of
glycans have been determined in numerous research areas such as immunity,
development and differentiation, biopharmaceuticals, cancer, fertilization, blood
types, infectious diseases, etc. Glycans are called as “cloths of cells” since they are
present on the surface of the cell and responsible for the signaling and communica-
tions between cells. Glycans can be classified in several ways. Varki divided the
biological roles of glycans into four main categories: (1) structural and modulatory
roles, (2) extrinsic (interspecies) recognition of glycans, (3) intrinsic (intraspecies)
recognition of glycans, and (4) molecular mimicry of host glycans. A total of 50
distinct roles are defined under these main categories [1].
Glycans perform huge range of biological function due to the diversity of them,
and they have significant roles in several physiological and pathological events, such
Figure 1.
The degree of evolutionary conservation and informational diversity for the omics fields.
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as cell growth, cell signaling, cell-cell interactions, differentiation, and tumor
growth [11–13]. In biological systems, information is carried by glycans, which are
significant biomarker candidates for many diseases such as cardiovascular diseases,
deficiencies of immune system, genetically inherited disorders, several cancer
types, and neurodegenerative diseases [14–16]. Alteration of glycan expression is
observed during the development and progression of these diseases, which is caused
by misregulated enzymes such as glycosyltransferases and glycosidases. As a result,
altered glycan structures have potential use for the identification of these diseases at
an early stage. Besides significant role of glycans in diagnosis and management of
disease, they can be used as therapeutics, markers for identification and isolation of
special cell types, and targets in discovery of drugs [17–19]. Moreover, glycans can
be considered as an ideal target for vaccines due to the presence of them on the
surface of several different pathogens and malignant cells. High affinity and exqui-
site specificity of other molecules to recognize glycans are a vital point of develop-
ments in the research of glycans and related diagnostics and therapeutic
applications.
3. Glycomics
Glycosylation plays significant roles in many biological processes including
growth and development of cell, tumor growth and metastasis, immune recognition
and response, intercommunication of cells, and microbial pathogenesis. As a result,
glycosylation of proteins is the one of the most common and significant posttrans-
lational modifications of proteins [20, 21]. Furthermore, more than half of proteins
undergo glycosylation [6]. Many issues such as genetic factors, nucleotide levels of
monosaccharides, cytokines, metabolites, hormones, and ecological factors can
affect and change glycosylation process [20–24]. Thus, integration of omics
approaches (e.g., proteomics, genomics, transcriptomics, and metabolomics) to the
field of glycobiology is essential to view the big picture of the whole biological
system [20, 21, 25]. Furthermore, for the analysis of glycans and glycosylation
pathways, many glycoinformatics tools and databases are now accessible [6].
Glycomics is one of the most recent types of omics area which is responsible for
the structure and function evaluations of glycans in bio-systems [26]. Integrating
glycomics to other fields of omics provides new system-scale insights in integrative
biology [27].
Moreover, glycomics informs other crucial scholarships such as systems
glycobiology and personalized glycomedicine that collectively aim to explain the
role of glycans in person-to-person and between population variations in disease
susceptibility and response to health interventions such as drugs, nutrition, and
vaccines. Glycosylation is present in both normal and diseased individuals [1].
Abnormal glycosylation is observed in a variety of diseases. Difference between
glycosylation patterns of healthy and diseased individuals can be used as
glycobiomarkers in personalized medicine [28]. As a result, many new medical
implications will be enabled by glycobiology and glycopathology [29]. Development
of glycomedicine can be contributed by holistic approach of functional and struc-
tural glycomics, which have applications in therapy development, fine-tuning
immunological responses and the performance of therapeutic antibodies and
boosting immune responses [28, 30]. Many applications of glycan arrays are present
in many fields, from basic biochemical research to biomedical applications [31]. In
addition to shotgun glycan microarrays [32], cell-based array resource has been
developed [33]. These developments enable deeper understanding of the many
biological roles of the glycome. Nevertheless, multiplatform and multiomics
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technologies are expected to further extend the knowledge of molecular mecha-
nisms of glycans.
3.1 Major glycomics techniques
Monosaccharides represent four free hydroxyl groups for the linkage of
another monosaccharide. As a result of this, glycans have more complex structure
compared to structure of peptides and nucleic acids. It is known that glycans are more
than the sequential monosaccharides; monomer types, modifications, the position of
modifications around the ring of sugar, glycopolymer branching, and linkages chiral-
ity are the factors that are responsible for the complexity. As a result, sequencing
techniques used for peptides or DNA (Sanger or Edman sequencing) are not appro-
priate for glycans. Moreover, most of the glycans are present as a part of a
glycoconjugate. Therefore, glycan part should be released from lipid or protein part,
by the use of enzymatic or chemical methods and isolated for analysis.
In the last decades, a number of techniques developed and applied to determine
structure of the glycans with different degrees of detail [34]. A traditional method is
to label the glycoconjugates radioactively and then apply anionic exchange, gel
filtration, or paper chromatographic analyses prior and subsequent to enzymatic or
chemical treatments. Still, it is difficult to figure out the definition of the actual
structure; in consequence, in earlier studies, if adequate amounts were present, gas
chromatography together with mass spectrometry (GC-MS) and/or nuclear mag-
netic resonance (NMR) studies were performed. However, these analyses involve
special expertise to perform the research and interpret the results, particularly if
standards were unavailable to compare with results.
HPLC and UPLC have superseded simple chromatography systems in recent
years, and radioactive labeling has been replaced by fluorescent labeling. Nowa-
days, variable columns such as graphitized carbon, reversed-phase (RP), anion
exchange, normal phase, or hydrophilic interaction resins can be used along with
suitable enzymatic/chemical treatments. A less used alternative is to analyze gly-
cans at elevated pH. As a result of this, the hydroxyl side chain deprotonation
occurs, that enables the usage of anion exchange together with amperometric
detection (HPAEC-PAD). On the other hand, glycan structure cannot be defined
only by HPLC retention times, and for the unknown structure, analyses in the
absence of standards should be interpreted with attention [35].
With the improvements in the types and the sensitivity, contribution of mass
spectrometer to studies of glycans and glycoconjugates has increased in the last
decades [36, 37]. At first, for the analysis of variable types of glycopolymers from
different sources, researchers used fast atom bombardment mass spectrometers
(FAB-MS). For the analyses with FAB-MS, chemical modifications such as methyl-
ation and acetylation were required. As an alternative method, matrix-assisted
laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
was developed and analysis of both permethylated and native glycans can be
performed with MALDI-TOF MS. Furthermore, current numerous electrospray
techniques with many detector types have significance in glycomics. Mainly, a
significant point in MS-based analysis is the capability to obtain glycan fragments.
Besides, the preparation and separation techniques are of great importance to
obtain the best results. As a consequence, liquid chromatography-mass spectrome-
try (LC-MS) in a number of forms is in general necessary since glycans with low
abundancy or poor ionization capacity can be suppressed in the case of whole
glycome examination. Moreover, reanalysis after the treatment of a chemical and an
enzyme results in maximization of the ability to obtain clear results from the
existing data.
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Glycan is generally a part of the glycoconjugate; thus, glycoproteomics and
glycolipidomics that consider both peptide/lipid and glycan parts are significant
fields. At this point, mass spectrometry technique comes into prominence [38].
Both glycan and polypeptide/lipid parts can be studied with this technique. On the
other hand, glycan parts of glycoproteins and glycolipids can be in various forms
even if the polypeptide/lipid part is same, defined as microheterogeneity. The
nature of glycan modifications is non-template driven and that leads to mentioned
microheterogeneity [39].
Blotting technique can be used for simple screens. Reagents such as lectins and
anti-carbohydrate antibodies with low specificity are often used for this technique;
as a result, misleading results are often obtained [40]. Still, lectins, and antiserums
have significance for immune responses in animals. New array-based systems can
provide essential clues on proteins bounded to glycans [41].
4. Systems glycobiology and integration of omics data sets
Developments in integrative informatics and systems biology of glycans based
on a holistic approach can make available a more comprehensive analysis. It eluci-
dates annotation of glycans, enzyme levels, abundances of glycans biosynthesis
pathways, and other omics data sets which are complementary. Though, several
tools are developed for proteomics and genomics data sets and standard bioinfor-
matics approaches are used in these tools, the complex relationships between
diverse components (such as glycans, enzymes, transporters, and sugar nucleo-
tides) of the glycosylation process are not considered by most of the existing
bioinformatics tools. Consequently, the use of these tools for glycomics data sets has
some limitations. The genome does not encode glycans directly and unlike proteins,
interconnected action of many enzymes provides assembly of glycans. Due to
mentioned limitations, developments in glycan analysis tools and methods have
been delayed and most of the present glycoinformatics tools are special for single
type data analysis [42–45]. For instance, database matching between obtained MS
results and specific glycans in a glycan library is used as a mutual method for MS-
based glycoprofiling for the purpose of individual peak annotation [46, 47]. If the
complexity of glycosylation is wanted to be considered, enzymes of the organism
which synthesize the studied glycans should generate glycan structures used for the
annotation of the spectrum [48]. Due to this alignment, activities of enzyme and
those structures assigned to each peak in the same spectrum will be consistent.
Although many omics approaches have significant progress in the last decades,
existing techniques of bioinformatics are still unsatisfactory for the integration of
varied data sets [49–51]. For instance, relations between expression levels of gene
and specific glycan linkages abundance are investigated by statistical database-
driven approaches, and these approaches could not predict quantity of detailed
glycan distributions [50, 51]. This indicates the necessity of glycoinformatics and
systems biology tools integration for the identification of glycan structure and these
should be also linked to the information of gene expression responsible for glyco-
sylation enzymes which synthesize these glycans. In order to understand levels of
mRNA which is related with the distribution and quantity of glycans present within
healthy and diseased cells, mathematical modeling of glycosylation is considered as
a promising method [48, 49, 52].
Variability in the platform of analytical high-throughput experiments can be
reduced by data integration approach. Increased confidence of biomarker predic-
tions and recommendations can be obtained if different data from experiments
such as glycogenes expression information or mass spectra profile confirm the
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results from integrative glycoinformatics and systems glycobiology tools.
Although integrated glycoinformatics tools have limitations in analytical
sensitivities, analysis and comparison of various results with various platforms are
enabled by these tools [6].
The integration of glycomics with other various omics data is promising for
further innovation in diagnosis and treatment of diseases [30]. The start point of
multiomics data integration is to sort the data based on the omics level. In the
following part, association between glycomics and other omics levels will be
represented.
4.1 Genomics
Integration of glycomics with genetic sequence can be occur in a number of
ways. For instance, glycosylation site can be gained or lost with the variation of
sequence. A single-nucleotide polymorphism (SNP) affects glycosylation of
prostate-specific antigen (PSA) and an altered function of it increases the risk of
prostate cancer. Functional analysis indicated that the stability and structural con-
formation of PSA are affected by missense variant rs61752561, which causes an
additional extra glycosylation site [53]. Furthermore, computational studies
revealed that variations in cancer somatic cells have potential to cause gain or loss of
glycosylation. In addition to SNP, variations in structure and abnormalities in cyto-
genetics could be integrated with glycomics. Cytogenetic abnormalities have been
associated with glycome expression [54]. A particular glycosyltransferase can gly-
cosylate numerous proteins, so genetic variants of it have extraordinary significance
because function of many glycoproteins can be affected by a single difference in
activity of enzyme. Several downstream pathways and cell metabolism can be
affected by a genetic or epigenetic variant that is called pleiotropic effect of genetic
or epigenetic variant on glycosylation [55].
4.2 Transcriptomics
Most of the glycomics research have been done at the level of transcriptome,
which can be performed either at a particular locus or with a technology of micro-
array. In colorectal cancer (CRC), glycosyltransferase ST6GAL1 is associated with
cancer, and altered ST6GAL1 expression was found by The Cancer Genome Atlas
(TCGA) mining [56]. Moreover, in order to identify differential expression of
glycosylation-related genes Saravanan et al. [57] used GLYCOv2 glycogene micro-
array technology. In the further studies, myeloma was compared with normal
plasma cell samples and 60 upregulated and 20 downregulated genes were found
among 243 genes in glycan-biosynthesis pathway [54]. A novel molecular signature
that is enriched for enzymes of glycosylation was revealed by meta-analysis
performed for gene expression of prostate cancer [58]. Additionally, hepatocellular
carcinoma was investigated by reviewing gene expressions that are related with
core fucosylation of the disease [59]. More systematic reviews and meta-analyses
are required to develop reliable biomarkers.
4.3 Glycoproteomics
Studies on glycoproteomics include peptide structures, glycan structures, and
sites of glycosylation [30]. Single site on the peptide chain can be glycosylated by
different glycans, and by this way, glycans can modulate function of the protein
[60]. In the literature, diverse techniques were associated with different pheno-
types, for instance, breast cancer, colon cancer, liver cancer, skin cancer, ovary
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cancer, bladder cancer, and neurodegenerative diseases, and additionally, a number
of structural variations including sialylation, fucosylation, degree of branching, and
specific glycosyltransferases expression [61–63]. For instance, cerebrospinal fluid
N-glycoproteomics is of significant importance in early diagnosis of Alzheimer’s
disease. Glycosylation patterns were assessed in patients and therapeutics targets
such as glycoenzymes were suggested [63]. For the diagnosis of pancreatic cancer,
specific glycoforms together with protein levels should be measured to improve
potential for diagnosis [64]. Glycoproteins constitute the majority of protein tumor
markers approved by Food and Drug Administration (FDA), and they are also used
currently in clinical practice. Many of these glycoproteins have alterations of glyco-
sylation in cancer [60]. MUC-1 (CA15-3/CA27.29) [65] and plasminogen activator
inhibitor (PAI-1) [66] are biomarkers of breast cancer; beta-human chorionic
gonadotropin (Beta-hCG) [67] is biomarker of colorectal cancer; alpha-fetoprotein
(AFP) [68] is a biomarker of liver cancer and germ cell tumors; chromogranin A
(CgA) [69] is a biomarker of neuroendocrine tumors; MUC16 (CA-125) [70] and
HE4 [71] are biomarkers of ovarian cancer; and many other biomarkers are present
for a variety type of cancer. Most of the results in the existing publications are
heterogeneous; thus, systematic integrative reviews of the literature are required
for further development of glycoproteomics.
4.4 Metabolomics
Metabolomics is the large-scale study of the small molecule substrates that
investigates variations in the metabolites within cells, biofluids, tissues, or organ-
ism. Metabolomics and glycomics were investigated in the research of post-
traumatic stress [72]. According to the researchers of this study, these biomarkers
together with omics markers should be integrated to understand the biological
differences responsible for this stress. For discovery of liver cancer biomarker,
proteomics, glycomics, and metabolomics were integrated and this integration
enhanced performance when compared to separate omics data [73]. Physiological
and pathological conditions are reflected by metabolomic and glycomic data in
individuals. Similar to metabolites, small glycans can be quantified easily [74].
Human Metabolome Database (HMDB) is the most inclusive metabolite source that
offers significant resource for the discovery of biomarkers in glycomics [75].
4.5 Glycolipidomics
Glycolipidomics is a scientific field that identifies and quantifies glycolipids. For
the determination of physiological and pathological conditions of individual, glyco-
lipids can be used as a specific biomarker. They take role in development of neuro-
logical and neurodegenerative diseases, such as Lewy body dementia, Alzheimer’s
disease, Parkinson’s disease, and frontotemporal dementia [30]. Furthermore,
glycosphingolipids are associated with cancer and they are promising molecules for
diagnosis as biomarkers and for malignant tumor immunotherapy as target [76].
More recently, Dehelean et al. [77] reviewed trends in the discovery of glycolipid
biomarker by MS.
4.6 Interactomics
Interactomics is the research field that investigates whole set of interactions
between molecules including glycans. Interaction of glycans with glycan-binding pro-
teins (GBPs) is of significant importance in immune response, signaling, cell recogni-
tion, infections, neurodegenerative diseases, and cancer. High-throughput
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technologies ease studies also on interactomics [78]. UniLectin3D is a database that
catalog lectins that aremost studiedGBPs. Database consists of curated information on
3D structures and interacting ligands [79]. Lectin-glycan interaction on surface of the
cell is a significant factor for the regulation in corneal biology (i.e., corneal infection)
and pathophysiology (i.e., inflammation) [80]. The whole protein-glycan interactome
information has not been obtained yet [41]. For future studies, estimated number of
interactions is of importance. GenProBiS is a bioinformatics tool that analyzes binding
sites between peptide-peptide, peptide-nucleic acid, and peptide-compound and also
sites of glycosylation and other posttranslational modifications. Furthermore, it pro-
vides maps between sequence variations and structure of protein. More developments
of bioinformatics tools analyzing huge data will prioritize the objections for experi-
mental verification and provide contribution to interactomics development.
4.7 Other omics fields
In future studies, many other omics fields should be associated with glycomics
such as comparative genomics, epigenomics, regulomics, NcRNomics, MiRNomics,
LncRNomics, etc. Although glycomics is the significant field related with molecular
interactions, information about how these complex processes controlled by
regulatory network is still inadequate. In addition to classic omics fields, omics
applications such as iatromics, environmental omics, pharmacogenomics, and
nutrigenomics should also be reviewed.
5. Bioinformatics tools and databases
Glycoinformatics combines bioinformatics tools with glycome. Glycomics data
is collected by the tools and databases to investigate, reveal, and associate with
other repository of related data of proteomics, genomics, and interactomics.
Commonly used tools and databases are summarized in Table 1.
6. Current bottlenecks for systems glycobiology
System-based analyses applied smoothly to network of signaling, metabolic
processes, and physiological modeling; however, applications in systems
glycobiology still have problems in computational and analytical studies and this
situation arises from prominent bottlenecks [81]: (i) there is no accepted standard
for model building; (ii) glycoinformatics databases are underdeveloped; (iii) and
insufficient quantitative data are from glycoproteomics experiments.
In recent years, many systems based models have been developed to simulate
biosynthesis of glycans. Nevertheless, difficulty in the incorporation of glycan
structure and specificity data of enzymes related with glycosylation into mathe-
matical models. As a result of this difficulty, systematic model building is still not
present in this field. Moreover, limited number of the current models is available in
Systems Biology Markup Language (SBML) format [82], which is the obstacle to
develop, share, and validate computational models.
In the last decades, many databases related to glycoscience have emerged. Nev-
ertheless, functional information is limited when compared to glycan structure and
taxonomy data. In the future, relation of glycan structure to specific enzymes that
synthesize them, the rates of their synthesis, and also their function are required in
order to build model.
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Name Description Link
Databases CAZY Describes the families of structurally
related catalytic and carbohydrate
binding modules (or functional
domains) of enzymes that degrade,
modify, or create glycosidic bonds
http://www.cazy.
org/
KEGG GLYCAN The KEGG GLYCAN structure
database is a collection of
experimentally determined glycan
structures. It contains all unique
structures taken from CarbBank,
structures entered from recent
publications, and structures present
in KEGG
https://www.ge
nome.jp/kegg/glyca
n/
Glycan Library A list of approximately 830 lipid-
linked sequence-defined glycan
probes derived from diverse natural
sources or chemically synthesized
https://glycoscience
s.med.ic.ac.uk/glyca
nLibraryIndex.html
GlycoMob An ion mobility-mass spectrometry
collision cross-section database for
glycomics
http://www.glyc
omob.org
GlycoBase 3.2 A database of over 650 N- and O-
linked glycan structures of HPLC,
UPLC, exoglycosidase sequencing,
and mass spectrometry (MALDI-
MS, ESI-MS, ESI-MS/MS, LC-MS,
LC-ESI-MS/MS) data
https://glycobase.
nibrt.ie/glycobase/
show_nibrt.action
Glyco3D A portal of 3D structures of mono-,
di-, oligo-, and polysaccharides and
carbohydrate recognizing proteins
(lectins, monoclonal antibodies,
glycosyltransferases) and
glycosaminoglycan binding proteins
http://glyco3d.ce
rmav.cnrs.fr/home.
php
GlyMAP An online resource mapping of the
variational landscape of glycoactive
enzymes
http://glymap.glyc
omics.ku.dk/
Glycosciences.de A collection of databases and
bioinformatics tools for glycobiology
and glycomics
http://glycosciences.
de/index.php
UniProtKB The universal protein sequence
database with information on
glycosylated proteins
http://www.uniprot.
org/
UniCarbKB UniCarbKB is a curated and
annotated glycan database which
curates information from the
scientific literature on glycoprotein-
derived glycan structures. It
includes data previously available
from GlycoSuiteDB
http://www.
unicarbkb.org/
UniCarbDB UniCarbDB is a platform for
presenting glycan structures and
fragment data characterized by LC-
MS/MS strategies. The database is
annotated with high-quality datasets
and is designed to extend and
reinforce those standards and
http://unicarb-db.b
iomedicine.gu.se/
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Name Description Link
ontologies developed by existing
glycomics databases
UniPep A database for human N-linked
glycosites: a resource for biomarker
discovery
http://www.unipep.
org
SugarBindDB SugarBindDB provides a collection
of known carbohydrate sequences to
which pathogenic organisms
specifically adhere via lectins or
adhesins. The data were compiled
through an exhaustive search of
literature published over the past
30 years by glycobiologists,
microbiologists, and medical
histologists
http://sugarbind.
expasy.org/
Consortium for Functional
Glycomics (CFG)
The CFG serves to combine the
expertise and glycomics resources to
reveal functions of glycans and
glycan-binding proteins (GBPs) that
impact human health and disease.
The CFG offers resources to the
community, including glycan
array screening services, a
reagent bank, and access to a
large glycomics database and data
analysis tools
http://www.func
tionalglycomics.org/
GLYCONAVI A Website for carbohydrate
research. It consists of the
“GlycoNAVI database” for
molecular information of
carbohydrates, and chemical
reactions of carbohydrate synthesis,
the “Route Searching System for
Glycan Synthesis,” and “GlycoNAVI
tools” for editing two-dimensional
molecular structure of
carbohydrates
http://www.glycona
vi.org/GlycoNAVI
GlycoGeneDataBase (GGDB) Glycogene includes genes associated
with glycan synthesis such as
glycosyltransferase, sugar
nucleotide synthases, sugar-
nucleotide transporters,
sulfotransferases, etc.
https://acgg.asia/
ggdb2
Carbohydrate Structure Data
Base (CSDB)
CSDB covers information on
structures and taxonomy of natural
carbohydrates published in the
literature and mostly resolved by
nuclear magnetic resonance (NMR).
CSDB is composed of two parts:
Bacterial and Archeal (BCSDB) and
Plant and Fungal (PFCSDB)
http://csdb.glycoscie
nce.ru/database/c
ore/help.php?topic=
rules
EXPASy This section of the ExPASy server
gathers a toolbox for processing data
as well as simulating, predicting, or
visualizing information, relative to
glycans, glycoproteins, and glycan-
binding proteins
http://www.expasy.
org/glycomics
10
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Name Description Link
TOOLS CASPER A tool for calculating NMR chemical
shifts of oligo- and polysaccharides
http://www.casper.
organ.su.se/casper/
Glycan Builder A software library and set of tools to
allow the rapid drawing of glycan
structures with support for all of the
most common symbolic notation
formats
http://www.unicarb
kb.org/builder
GlycoDomainViewer An online resource to study site
glycosylation with respect to protein
context and conservation
http://glycodomain.
glycomics.ku.dk/
Glynsight Glynsight offers visualization and
interactive comparison of glycan
expression profiles. The tool was
initially developed with a focus on
IgG N-glycan profiles but it was
extended to usage with any
experiment, which produces N- or
O-linked glycan expression data
https://glycoprote
ome.expasy.org/g
lynsight/
GlycoMinestruct A new bioinformatics tool for highly
accurate mapping of the human N-
linked and O-linked glycoproteomes
by incorporating structural features
http://glycomine.erc
.monash.edu/Lab/
GlycoMine_Struct/
GlyMAP An online resource mapping out the
variational landscape of glycoactive
enzymes
http://glymap.glyc
omics.ku.dk/
GlycoMod An online tool to predict
oligosaccharide structures on
proteins from experimentally
determined masses
http://web.expasy.
org/glycomod/
GlycoMiner/GlycoPattern Software tools designed to detect,
characterize, and perform relative
quantitation of N-glycopeptides
based on LC-MS runs
http://www.szki.ttk.
mta.hu/ms/glyc
ominer/
Glycosciences.de A collection of databases and
bioinformatics tools for glycobiology
and glycomics
http://glycosciences.
de/index.php
RINGS AWeb resource providing
algorithmic and data mining tools to
aid glycobiology research
http://rings.t.soka.
ac.jp/
MonosaccharideDB A comprehensive reference source
for monosaccharide notation
http://www.
monosaccharidedb.
org/start.action
NetOGlyc Next generation prediction of O-
glycosylation sites on proteins
http://www.cbs.dtu.
dk/services/Ne
tOGlyc/
GlycoSpectrumScan A Web-based bioinformatic tool
designed to link glycomics and
proteomics analyses for the
characterization of glycopeptides.
GlycoSpectrumScan is a MS
platform which is independent,
freely accessible, and profiles
glycopeptide MS data using
beforehand separately acquired
released glycan and proteomics
https://github.com/
wliu1197/glycospec
trumscan
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For the measurement of glycome, two main approaches are common. In the first
approach, enzymes or mild hydrolysis is used to separate the glycans from the
peptide backbone. Next, to obtain information about the composition and relative
abundance of the carbohydrate structures, permethylation of glycans and MS anal-
ysis are used [83]. The bottleneck is the lack of well-developed software. For the
data analysis of glycoproteomics and correspondingly acceleration of system-based
model building and validation, more sophisticated computational tools are required.
7. Mathematical modeling of biochemical reaction networks
Mathematical models of glycosylation are developed in three main stages: (i)
biological information gathering; (ii) model formulation; (iii) and simulation and
postsimulation analysis. First step includes definition of components (enzyme,
substrate, and product) crucial for the model. All of the components present in the
biochemical network and connections between them are cataloged in this step. The
process relies on information of biochemistry and cell biology, and analytical tools.
In the next step, behavior in the steady state of the system is investigated by using
Name Description Link
information. Both N- and O-
glycosylated peptides as well as
multiply glycosylated peptides can
be analyzed
SimGlycan A predictive carbohydrate analysis
tool for MS/MS data
http://www.premie
rbiosoft.com/glycan
SugarQb SugarQb enables genome-wide
insights into protein glycosylation
and glycan modifications in complex
biological systems. This is a
collection of software tools (Nodes)
which enable the automated
identification of intact glycopeptides
from HCD‐MS/MS data sets, using
commonly use peptide-centric MS/
MS search engines
http://www.imba.
oeaw.ac.at/SugarQb
GlycoDigest GlycoDigest is a tool that simulates
exoglycosidase digestion based on
controlled rules acquired from
expert knowledge and experimental
evidence available in GlycoBase
www.glycodigest.
org/
Virtual Glycome This Website is focused on
presenting selected computational
tools and experimental resources
that can be used to better
understand the processes regulating
cellular glycosylation at multiple
levels
https://virtualglyc
ome.org/
SweetUnityMol Software to display 3-D structures of
carbohydrates, polysaccharides, and
glycoconjugates
http://sourceforge.
net/projects/
unitymol/files/
Table 1.
Tools and databases used in glycoinformatics.
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simple linear algebra and principles of optimization. If time is a variable, the com-
puter model can incorporate ordinary differential equations (ODEs) or Boolean
networks. Proper kinetic/thermodynamic/stochastic/optimization parameters are
collated depending on the formulation nature of the model and processes which are
specified by enzymatically/nonenzymatically. The last step is performed to simulate
the experimental system in the computer and to define unknown parameters of
model by the help of fitting experimental data [81]. Visualization of
multidimensional results is significant because numerous diverse models may
attempt to fit one data set obtained from time labor and concentration-dependent
experiments. As a result, consolidation of the findings obtained by simulations of
complex reaction network and generation of hypotheses that can be tested experi-
mentally require network analysis strategies.
8. Conclusions
Glycomics is a very comprehensive research area of science and interacts with
several different omics fields. As many other omics types, it consists of a huge
number of genomics components. In the future, techniques in high-throughput
analysis and bioinformatics will be developed and enable the integration of all
available data of glycomics into a particular diagram and by this way, it will be
possible to develop biomarker and identify potential new therapeutic targets.
Moreover, progresses in the field reveal that integrative multiomics approach
should include glycomics in order to develop new biomarkers for robust diseases.
One of the specific fields of systems biology is the systems glycobiology. It is based
on a holistic approach that indicates process of complex glycosylation and associa-
tions between its constituents. A more complete glycome overview is targeted by
using enzyme levels, abundances of glycans, pathways for biosynthesis, glycan
annotation, and related omics data sets.
An approach of systems glycobiology is constructed in combination of various
data sets of glycomics with that of other omics fields by the use of glycoinformatics
tools to clarify understanding on process of glycosylation from various data sets.
With the presented chapter, main aspects of glycobiology, glycomics, and systems
glycobiology are summarized. However, these fields are still developing and further
developments provide more insight to this specific research area.
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